A US research institute has put an early stop to a large trial investigating whether taking low-dose methotrexate could prevent heart attacks, strokes, or death in people with prior MI and either type 2 diabetes or the metabolic syndrome. The halting of the large Cardiovascular Inflammation Reduction (CIRT) Trial. by the National Heart, Lung and Blood ...
Research institute halts large cardiovascular inflammation trial
24 May 2018